Co-Occurrence of Plasmid-Mediated AmpC β-Lactamase Activity Among Klebsiella pneumoniae and Escherichia Coli
Open Access
- 26 September 2017
- journal article
- Published by Bentham Science Publishers Ltd. in The Open Microbiology Journal
- Vol. 11 (1) , 195-202
Abstract
Introduction: Extended-spectrum β-lactamases (ESBLs), including the AmpC type, are important mechanisms of resistance among Klebsiella pneumoniae and Escherichia coli isolates. Objective: The aim of the study was to investigate the occurrence of AmpC-type β-lactamase producers isolated from two hospitals in Tripoli, Libya. Methods: All clinical isolates (76 K. pneumoniae and 75 E. coli) collected over two years (2013-2014) were evaluated for susceptibility to a panel of antimicrobials and were analyzed phenotypically for the ESBL and AmpC phenotype using E-test and ESBL and AmpC screen disc test. Both ESBL and AmpC-positive isolates were then screened for the presence of genes encoding plasmid-mediated AmpC β-lactamases by polymerase chain reaction (PCR). Results: Of the K. pneumoniae and E. coli tested, 75% and 16% were resistant to gentamicin, 74% and 1.3% to imipenem, 71% and 12% to cefoxitin, 80% and 12% to cefepime, 69% and 22.6% to ciprofloxacin, respectively. None of the E. coli isolates were multidrug resistant compared with K. pneumoniae (65.8%). K. pneumoniae ESBL producers were significantly higher (85.5%) compared with (17.3%) E. coli isolates (P K. pneumoniae, and 4% E. coli isolates. There was low agreement between phenotypic and genotypic methods, phenotypic testing underestimated detection of AmpC enzyme and did not correlate well with molecular results. The gene encoding CMY enzyme was the most prevalent (66.6%) of AmpC positive isolates followed by MOX, DHA and EBC. Only one AmpC gene was detected in 5/9 isolates, i.e, blaCMY (n=3), bla MOX (n=1), blaDHA (n=1). However, co-occurrence of AmpC genes were evident in 3/9 isolates with the following distribution: bla CMY and blaEBC (n=1), and blaCMY and blaMOX (n=2). Neither blaFOX nor blaACC was detected in all tested isolates. All AmpC positive strains were resistant to cefoxitin and isolated from patients admitted to intensive care units. Conclusion: Further studies are needed for detection of other AmpC variant enzyme production among such isolates. Continued surveillance and judicious antibiotic usage together with the implementation of efficient infection control measures are absolutely required.Keywords
This publication has 33 references indexed in Scilit:
- An Increase in the Clinical Isolation of Acquired AmpC β-Lactamase-Producing Klebsiella pneumoniae in Korea from 2007 to 2010Annals of Laboratory Medicine, 2013
- Prevalence of AmpC and SHV β-Lactamases in Clinical Isolates of Escherichia coli From Tehran HospitalsJundishapur Journal of Microbiology, 2013
- Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in SpainEuropean Journal of Clinical Microbiology & Infectious Diseases, 2012
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistanceClinical Microbiology and Infection, 2012
- Characterization and Molecular Epidemiology of Extended-Spectrum β-Lactamases in Clinical Isolates of Enterobacteriaceae in a Tunisian University HospitalMicrobial Drug Resistance, 2010
- Extended-Spectrum-β-Lactamase, AmpC, and Carbapenemase IssuesJournal of Clinical Microbiology, 2010
- Prevalence of plasmid-mediated AmpC β-lactamases among Enterobacteriaceae in Algiers hospitalsInternational Journal of Antimicrobial Agents, 2009
- AmpC β-LactamasesClinical Microbiology Reviews, 2009
- Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered in a French hospitalJournal of Antimicrobial Chemotherapy, 2008
- First Detection of the Ambler Class C 1 AmpC β-Lactamase in Citrobacter freundii by a New, Simple Double-Disk Synergy TestJournal of Clinical Microbiology, 2006